Europe · Exchanges & live quotes · Boursier.com

Bayer relève sa prévision de bénéfice annuel, sa division pharmaceutique dépasse les attentes au T3

Published by Boursier.com · France 12 h ago

3 novembre (Reuters) - Bayer a relevé mardi son objectif de bénéfice pour 2026, invoquant des résultats supérieurs aux attentes dans sa division pharmaceutique.

Read the full article on Boursier.com Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.boursier.com)

Also worth reading

Euronext

OPEC+ agrees in principle to keep oil output targets steady in December, sources say

London Stock Exchange Group

LSEG to acquire Octus, creating market leader across public and private credit solutions

ABC Bourse

Bayer relève sa prévision de bénéfice annuel, sa division pharmaceutique dépasse les attentes au T3

Share

Also worth reading

OPEC+ agrees in principle to keep oil output targets steady in December, sources say

LSEG to acquire Octus, creating market leader across public and private credit solutions

CAC 40: La Bourse de Paris plie avant les élections de mi-mandat aux Etats-Unis